Catumaxomab

Korjuny 50 microgram, concentraat voor oplossing voor infusie

Concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 10 Feb 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

KorjunyEuropean UnionAuthorised

Korjuny 10 Microgramos Concentrado Para Solucion Para PerfusionSpain · 10 µg · concentrado para solución para perfusión · Atnahs Pharma Netherlands Bv.Same brand
Korjuny 50 Microgramos Concentrado Para Solucion Para PerfusionSpain · 50 µg · concentrado para solución para perfusión · Atnahs Pharma Netherlands Bv.Same brand
KorjunyEuropean Union · Atnahs Pharma Netherlands B.V.Same brand
KorjunyCroatiaSame brand
RemovabCanada · 0.1 MG / ML · Solution · Fresenius Biotech GMBHSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Catumaxomab

Korjuny 50 microgram, concentraat voor oplossing voor infusie

Concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 10 Feb 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

KorjunyEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

RemovabCanada · 0.1 MG / ML · Solution · Fresenius Biotech GMBH

RemovabEuropean Union · Neovii Biotech GmbH

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Catumaxomab
Dosage form: Concentraat voor oplossing voor infusie
Route: Intraperitoneaal gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 10 Feb 2025
Registration: EU/1/24/1826
Marketing authorisation holder: Atnahs Pharma Netherlands B.V.
ATC code: L01FX03
Group: Antineoplastic and immunomodulating agents
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/005697
EU number: EU/1/24/1826